Retraction notice to “389P Monocyte reprogramming in high-grade serous ovarian cancer and chemotherapy impact: A single-cell RNA sequencing study”: [Annals of Oncology. Volume 35, Supplement 4, December 2024, Page S1549]
Retraction notice to “389P Monocyte reprogramming in high-grade serous ovarian cancer and chemotherapy impact: A single-cell RNA sequencing study”: [Annals of Oncology. Volume 35, Supplement 4, December 2024, Page S1549]. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426067712?dgcid=rss_sd_all
Retraction notice to “389P Monocyte reprogramming in high-grade serous ovarian cancer and chemotherapy impact: A single-cell RNA sequencing study”: [Annals of Oncology. Volume 35, Supplement 4, December 2024, Page S1549]. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S0923753426067712?dgcid=rss_sd_all
“Retraction notice to “389P Monocyte reprogramming in high-grade serous ovarian cancer and chemotherapy impact: A single-cell RNA sequencing study”: [Annals of Oncology. Volume 35, Supplement 4, December 2024, Page S1549].” Annals of Oncology.
@article{article35801,
title = {Retraction notice to “389P Monocyte reprogramming in high-grade serous ovarian cancer and chemotherapy impact: A single-cell RNA sequencing study”: [Annals of Oncology. Volume 35, Supplement 4, December 2024, Page S1549]},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426067712?dgcid=rss_sd_all}
}